Live-cell imaging reveals redox metabolic reprogramming during zygotic genome activation.
Hao SunZhuo ZhangTianda LiTing LiWeicai ChenTianshi PanSen FangChao LiuYing ZhangLeyun WangGuihai FengWei LiQi ZhouYu-Zheng ZhaoPublished in: Journal of cellular physiology (2023)
Metabolic programming is deeply intertwined with early embryonic development including zygotic genome activation (ZGA), the polarization of zygotic cells, and cell fate commitment. It is crucial to establish a noninvasive imaging technology that spatiotemporally illuminates the cellular metabolism pathways in embryos to track developmental metabolism in situ. In this study, we used two high-quality genetically encoded fluorescent biosensors, SoNar for NADH/NAD + and iNap1 for NADPH, to characterize the dynamic regulation of energy metabolism and redox homeostasis during early zygotic cleavage. Our imaging results showed that NADH/NAD + levels decreased from the early to the late two-cell stage, whereas the levels of the reducing equivalent NADPH increased. Mechanistically, transcriptome profiling suggested that during the two-cell stage, zygotic cells downregulated the expression of genes involved in glucose uptake and glycolysis, and upregulated the expression of genes for pyruvate metabolism in mitochondria and oxidative phosphorylation, with a decline in the expression of two peroxiredoxin genes, Prdx1 and Prdx2. Collectively, with the establishment of in situ metabolic monitoring technology, our study revealed the programming of redox metabolism during ZGA.
Keyphrases
- single cell
- poor prognosis
- genome wide
- high resolution
- induced apoptosis
- cell fate
- cell cycle arrest
- rna seq
- cell therapy
- dna methylation
- reactive oxygen species
- type diabetes
- cell death
- fluorescence imaging
- mass spectrometry
- bioinformatics analysis
- stem cells
- weight loss
- gene expression
- living cells
- photodynamic therapy
- quantum dots